Menu Search
Equities

Health Catalyst Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
2YP:STU

Health Catalyst Inc

Actions
  • Price (EUR)1.81
  • Today's Change0.05 / 2.84%
  • Shares traded0.00
  • 1 Year change-65.19%
  • Beta1.7203
Data delayed at least 15 minutes, as of Feb 06 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Health Catalyst, Inc. is a provider of data and analytics technology and services to healthcare organizations. The Company's solution comprises its cloud-based data platform, applications, and expertise. Its segments include Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and earns primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally a combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its clients to fully configure and utilize the benefits of its technology offerings. Its clients, which are primarily healthcare providers, use its Solution to manage their data, derive analytical insights to operate their organization, and produce measurable clinical, financial, and operational improvements.

  • Revenue in USD (TTM)316.06m
  • Net income in USD-107.62m
  • Incorporated2011
  • Employees728.00
  • Location
    Health Catalyst Inc10897 SOUTH RIVER FRONT PARKWAY, #300SOUTH JORDAN 84095United StatesUSA
  • Phone+1 (801) 708-6800
  • Fax+1 (302) 655-5049
  • Websitehttps://www.healthcatalyst.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.